TheProductLawyers.com reports on recent research which may show a potential link between the use of Xarelto and serious health risks which have been claimed by plaintiffs in the multidistrict litigation (MDL) 2592 against the manufacturers of Xarelto—Bayer AG and Janssen Pharmaceuticals.
The latest FDA communication focused on the amount of time the filters should remain in the body, stating that they are removed within 29-54 days following the time of implantation except in cases where the risk of pulmonary embolism remains.
TheProductLawyers.com announces the finalized dates for bellwether trials in the mass litigation against Xarelto and its manufacturers—Bayer AG and Janssen Pharmaceuticals, a division of Johnson & Johnson Corporation.
The Legal Examiner offers both bloggers and readers the opportunity to share their thoughts and opinions on all things law. From news on current legislative efforts to practical guidance on everyday legal issues, The Legal Examiner will have it covered. Learn More